04262024Fri
Last updateWed, 27 Mar 2024 6am

The impact of motor and depressive symptoms on quality of life in patients with Parkinson's disease

Jiin-Ling Jianga, b, Sheng-Tzung Tsaic, d, e, Tsung-Cheng Hsiehb, Chi-Wei Leec, e, Sheng-Huang Linf, Shin-Yuan Chenc, d, e

a Department of Nursing, Tzu Chi University, Hualien, Taiwan
b Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan
c Department of Neurosurgery, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
d Parkinson's Clinical and Research Center, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
e Division of Functional Neuroscience, Neuro-Medical Scientific Center, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
f Department of Neurology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan

Full-Text HTML Download PDF


Abstract
Objective

To identify factors that affect the quality of life (QoL) of patients with idiopathic Parkinson's disease (IPD).

Materials and Methods

Twenty-seven IPD patients from Hualien Tzu Chi Hospital were enrolled between May, 2008 and July, 2012. All patients completed a Parkinson's disease-specific QoL questionnaire and the Beck Depression Inventory (BDI). A structured questionnaire interview and complete neurological examination, including the motor part of the Unified Parkinson's Disease Rating Scale (UPDRS part III), the Schwab and England Disability Scale (S & E), the Hoehn and Yahr Scale, and the Mini-Mental State Examination (MMSE) were administered by a nurse and a neurologist.

Results

The degree of depression and severity of disease were significantly correlated with the QoL of IPD patients (r = 0.49, p = 0.01, and r = 0.44, p = 0.02, respectively). The UPDRS part III, S & E, and MMSE scores did not correlate significantly with QoL scores (r = 0.22, p = 0.26, r = −0.36, p = 0.06, and r = −0.25, p = 0.22, respectively). The BDI-Ⅱdepression score accounted for 31.5% of the variance of the QoL scores.

Conclusion

Depression and disease severity have significant impacts on the QoL of IPD patients. Treatment profiles should encompass both motor and non-motor domains.

Keywords
Depression; Parkinson's disease; Quality of life


 

On the Cover

Search all Issue